Medical Mythbusting Commentary for December 4, 2024
Source:First new treatment for asthma attacks in 50 years
Reference:
Treating eosinophilic exacerbations of asthma and COPD with benralizumab (ABRA): a double-blind, double-dummy, active placebo-controlled randomised trial